JP Morgan Chase’s Rallybio RLYB Stock Holding History
Bought
Maintained
Sold
Other funds holding RLYB
ACM
TGA
PBPIA
NCM
AC
RC
JP Morgan Chase's RLYB Position: Q2 2026 in Review
JP Morgan Chase reduced its Rallybio (RLYB) stake by 100% in Q2 2026, selling an estimated $32K and leaving 9 shares worth $145. The position accounts for ﹤0.01% of the portfolio, ranked #7518.
JP Morgan Chase first reported a position in RLYB in Q3 2021 and has held it in 20 quarters since. The position peaked at $3.13M in Q4 2021. 37 funds tracked by Wall St. Rank hold RLYB as of Q2 2026.
- JP Morgan Chase held 9 shares of Rallybio worth $145 as of Q2 2026.
- JP Morgan Chase sold 2,488 Rallybio shares in Q2 2026, an estimated $32K.
- Rallybio made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7518 holding.
- JP Morgan Chase first reported a position in Rallybio in Q3 2021 and has held it in 20 quarters since.
- JP Morgan Chase's Rallybio position peaked at $3.13M in Q4 2021.
- 37 funds tracked by Wall St. Rank held Rallybio as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.